ESSA Pharma Stock (NASDAQ:EPIX)
Previous Close
$0.20
52W Range
$0.18 - $6.45
50D Avg
$0.83
200D Avg
$1.49
Market Cap
$9.52M
Avg Vol (3M)
$6.75M
Beta
1.53
Div Yield
$1.69 (840.47%)
EPIX Company Profile
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.